<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02397512</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-2014-0358</org_study_id>
    <nct_id>NCT02397512</nct_id>
  </id_info>
  <brief_title>Elucidating the Influence of Lactulose Intake on the Gut Microbiota Composition</brief_title>
  <acronym>Lactulose</acronym>
  <official_title>Elucidating the Influence of Lactulose Intake on the Gut Microbiota Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Federal Institute of Technology in Zurich (ETHZ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the influence of lactulose of the human gut microbiota. Healthy
      volunteers will ingest 50g of lactulose and donate stool samples 1 day before as well as 1-2
      days and 14 days after the test. Using sequencing and metabolomics techniques the
      investigators will identify changes in microbiota composition upon lactulose exposure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a clinical study for investigating the influence of lactulose on the composition and
      metabolic activities of the intestinal microbiota. We will recruit 40 healthy volunteers.
      Subjects will be randomized and receive either 50g lactose (intervention group) or 50g
      sucrose (control group).

      Subjects will donate fecal samples 24h before and after (1-2d, 14d) lactulose ingestion.
      After ingestion H2-in expiratory air and symptoms will be followed for 3 hours.

      Frozen samples will be analyzed for their microbiota composition and key metabolites.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">October 1, 2015</completion_date>
  <primary_completion_date type="Actual">October 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of lactulose intake on gut microbiota composition (microbiota sequencing, analysis of E. coli)</measure>
    <time_frame>1-2 days after ingestion of lactulose</time_frame>
    <description>microbiota sequencing, analysis of E. coli</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Influence of lactulose intake on metabolic profiles within the fecal ecoystem (metabolomics analysis)</measure>
    <time_frame>1-2 days after ingestion of lactulose</time_frame>
    <description>metabolomics analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of gut microbiota composition and H2-peak (H2-measurements)</measure>
    <time_frame>within 3 hours after lactulose ingestion</time_frame>
    <description>H2-measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of gut microbiota composition and symptoms (standardized record of symptoms)</measure>
    <time_frame>within 3 hours after lactulose ingestion</time_frame>
    <description>standardized record of symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Changes in Gut Microbiota Composition After Lactulose Exposure</condition>
  <arm_group>
    <arm_group_label>Lactulose group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will ingest 50g of lactulose once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will ingest 50g of sucrose once</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>application of lactulose</intervention_name>
    <description>Subjects will ingest 50g of lactulose once</description>
    <arm_group_label>Lactulose group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>application of sucrose</intervention_name>
    <description>Subjects will ingest 50g of sucrose once</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects free of relevant abdominal complaints (=healthy)

          -  Written informed consent

          -  Working at ETH Zurich/University of Zurich, experience in handling of -80Â°C freezers
             on biosafety level 2

        Exclusion Criteria:

          -  Previous history of gastrointestinal disease or surgery (excludes appendectomy, hernia
             repair and anorectal disorders)

          -  Known diabetes mellitus, scleroderma, neurological impairment or other major current
             disease

          -  Subjects unable to stop medication that alters gut flora: proton pump inhibitors,
             laxatives and antibiotics at least 4 weeks before study entry.

          -  Pregnancy beyond week 12 (no pregnancy test will be performed)

          -  Involvement in any other clinical trial during the course of this trial, nor within a
             period of 14 days prior to its beginning or 14 days after its completion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Misselwitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerhard Rogler, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Gastroenterology, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2015</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactulose</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

